目的 分析人类免疫缺陷病毒(human immune deficiency virus,HIV)阳性肾衰竭患者动静脉内瘘手术后感染与外周血CD4计数、白蛋白(ALB)的相关性。 方法 选取2016年7月—2023年10月成都市公共卫生临床医疗中心HIV阳性肾衰竭初次行动静脉内瘘手术患者,根据患者是否发生动静脉内瘘感染分为感染组和未感染组。Logistic分析动静脉内瘘手术后发生感染的影响因素,以Spearman法分析外周血CD4计数、ALB水平与感染可能性评分(infection probability score,IPS)、急性生理功能和慢性健康状况评分系统Ⅱ(acute physiology and chronic health evaluation,APACHEⅡ)的相关性。并通过受试者工作特征(ROC)曲线分析外周血CD4计数、ALB预测动静脉内瘘手术后发生感染的价值。 结果 共纳入96例患者,其中感染组20例,非感染组76例。感染组穿刺点反复穿刺率、穿刺点过敏率均高于未感染组(χ2=9.970、7.191,P=0.002、0.007);感染组外周血CD4计数、ALB水平低于未感染组(t=8.073、7.092,P=0.001、0.001)。穿刺点反复穿刺(OR=3.552,95% CI:1.186~10.637,P=0.001)、穿刺点过敏(OR=4.042,95% CI:1.245~13.120,P=0.001)、外周血CD4计数(OR=0.370,95% CI:0.182~0.753,P=0.001)、ALB水平(OR=0.356,95% CI:0.176~0.720,P=0.001)均为HIV阳性肾衰竭患者初次动静脉内瘘手术后发生感染的影响因素。感染组CD4计数<200个/μl患者IPS、APACHEⅡ评分高于CD4计数≥200个/μl患者(t=3.774、4.123,P=0.001、0.001),ALB<30 g/L患者IPS、APACHEⅡ评分高于ALB≥30 g/L患者(t=3.594、4.229,P=0.002、0.001);感染组外周血CD4计数、ALB水平与IPS、APACHEⅡ评分呈负相关(r=-0.576、-0.621、-0.562、-0.643,P=0.001、0.001、0.001、0.001);外周血CD4计数、ALB预测HIV阳性肾衰竭患者初次动静脉内瘘手术后发生感染的AUC分别为0.763、0.800,二者联合预测的AUC为0.947,大于单独预测的AUC(Z=2.793、2.078,P=0.007、0.035)。 结论 HIV阳性肾衰竭初次行动静脉内瘘患者手术后感染与外周血CD4计数、ALB水平密切相关,二者联合可为临床预测动静脉内瘘感染提供重要参考依据。
Objective To analyze the correlation between the infection after the arteriovenous fistula (AVF) surgery and the levels of peripheral blood CD4 count and albumin (ALB) in human immunodeficiency virus (HIV)-positive patients with renal failure undergoing hemodialysis. Methods A total of 96 patients with HIV-positive and renal failure primarily undergoing AVF surgery for hemodialysis at the Chengdu Public Health Clinical Medical Center from July 2016 to October 2023 were selected as the research subjects. They were divided into an infection group (20 cases) and an non-infected group (76 cases) based on whether they had AVF infection. Logistic regression was used to analyze the factors affecting the occurrence of infection after AVF surgery. Spearman correlation was used to analyze the correlation between peripheral blood CD4 count, ALB level, infection probability score (IPS), and acute physiology and chronic health evaluation II (APACHE II) score. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of peripheral blood CD4 count and ALB for the occurrence of AVF infection after the surgery. Results The repeated puncture rate and the rate of allergy at puncture site were 55.00% and 45.00% respectively in the infection group, higher than those of 19.74% and 14.47% respectively in the non-infection group (χ2=9.970 and 7.191; P=0.002 and 0.007). The peripheral blood CD4 count and ALB level were lower in the infected group than in the non-infected group (t=8.073 and 7.092; P=0.001 and 0.001). Repeated puncture at the puncture site (OR=3.552, 95% CI: 1.186~10.637, P=0.001), allergy at puncture site (OR=4.042, 95% CI: 1.245~13.120, P=0.001), peripheral blood CD4 count (OR=0.370, 95% CI: 0.182~0.753, P=0.001), and ALB level (OR=0.356, 95% CI: 0.176~0.720, P=0.001) were the factors affecting the occurrence of infection after the first AVF surgery in HIV-positive renal failure patients undergoing hemodialysis (P<0.05). In the infection group, patients with CD4 count <200 cells/μl had higher IPS and APACHE II scores than those with CD4 count ≥200 cells/μl (t=3.774 and 4.123; P=0.001 and 0.001); patients with ALB <30 g/L had higher IPS and APACHE II scores than those with ALB ≥30 g/L (t=3.594 and 4.229; P=0.002 and 0.001); peripheral blood CD4 count and ALB level were negatively correlated with IPS and APACHE II scores (r=-0.576, -0.621, -0.562 and -0.643 respectively; P=0.001, 0.001, 0.001 and 0.001 respectively). The area under the curves of peripheral blood CD4 count and ALB for predicting infection in HIV-positive renal failure patients undergoing hemodialysis after AVF surgery were 0.763 and 0.800 respectively; the area under the curve of combined use of peripheral blood CD4 count and ALB was 0.947, significantly greater than that of individual use of the two factors for the prediction (Z=2.793 and 2.078; P=0.007 and 0.035). Conclusion Infection after the first AVF surgery in HIV-positive renal failure patients is closely related to peripheral CD4 count and ALB level. Combined use of peripheral CD4 count and ALB level can provide an important reference to predict AVF infection.
[1] Sheykhhasan M,Foroutan A,Manoochehri H,et al.Could gene therapy cure HIV[J].Life Sci,2021,277(1):119451.DOI:10.1016/j.lfs.2021.119451.
[2] Ma YDY,Cui YR,Hu Q,et al.Long-Term Changes of HIV/AIDS Incidence Rate in China and the U.S. Population From 1994 to 2019: A Join-Point and Age-Period-Cohort Analysis[J].Front Public Health,2021,9(1):652868.DOI:10.3389/fpubh.2021.652868.
[3] Wu ZY,McGoogan JM,Detels R.The Enigma of the Human Immunodeficiency Virus (HIV) Epidemic in China[J].Clin Infect Dis,2021,72(5):876-881.DOI:10.1093/cid/ciaa835.
[4] 杨水秀,周贤位,张明玲,等.HIV血液透析患者深静脉血栓形成的危险因素分析[J].医学信息,2020,33(24):80-83.DOI:10.3969/j.issn.1006-1959.2020.24.022.
[5] Pinto R,Sousa C,Salgueiro A,et al.Arteriovenous fistula cannulation in hemodialysis: A vascular access clinical practice guidelines narrative review[J].J Vasc Access,202,23(5):825-831.DOI:10.1177/11297298211006972.
[6] 王慧,张佳馨,岳亚楠,等.血液透析患者动静脉内瘘系统化管理初探[J].武警医学,2020,31(10):898-899.DOI:10.3969/j.issn.1004-3594.2020.10.019.
[7] 祁燕伟,刘春云,刘立,等.HIV/HBV共感染患者免疫功能与肝组织纤维化的相关性研究[J].国际检验医学杂志,2023,44(1):34-39.DOI:10.3969/j.issn.1673-4130.2023.01.006.
[8] Wiedermann CJ.Hypoalbuminemia as Surrogate and Culprit of Infections[J].Int J Mol Sci,2021,22(9):4496.DOI:10.3390/ijms22094496.
[9] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心.中国艾滋病诊疗指南(2021年版)[J].中华内科杂志,2021,60(12):1106-1128.DOI:10.3760/cma.j.cn112138-20211006-00676.
[10] 赵茜,郭慧,吕畅,等.感染可能性评分及血清胆碱酯酶和淀粉样蛋白A与危重症感染患者生存情况的关系[J].中国医药,2020,15(12):1891-1895.DOI:10.3760/j.issn.1673-4777.2020.12.018.
[11] Luo Y,Wang ZY,Wang C.Improvement of APACHE II score system for disease severity based on XGBoost algorithm[J].BMC Med Inform Decis Mak,2021,21(1):237.DOI:10.1186/s12911-021-01591-x.
[12] 荣鹏,王素霞,贺靓靓.血液透析患者隐匿性自体动静脉瘘感染致多器官功能衰竭死亡1例[J].实用医药杂志,2020,37(10):925-927.DOI:10.14172/j.issn1671-4008.2020.10.018.
[13] 王丽玲.维持性血液透析患者动静脉内瘘感染的影响因素[J].医疗装备,2021,34(11):167-169.DOI:10.3969/j.issn.1002-2376.2021.11.082.
[14] Cao ZQ,Li JJ,Chen HH,et al.Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy[J].Sci Rep,2020,10(1):15875.DOI:10.1038/s41598-020-72701-4.
[15] 曹志强,王卫军,林兆森,等.广西钦州市2016—2018年新报告HIV感染者不同基因型首次CD4~+T细胞计数分析[J].中国热带医学,2020,20(5):397-401.DOI:10.13604/j.cnki.46-1064/r.2020.05.01.
[16] 郭武辉,张华.血清T淋巴细胞亚群检测在肝硬化合并真菌性血流感染中的诊断价值[J].陕西医学杂志,2021,50(12):1570-1572,1576.DOI:10.3969/j.issn.1000-7377.2021.12.026.
[17] Gwadu AA,Tegegne AS.Determinants of CD4 count and risk for death of HIV infected children under ART[J].Sci Rep,2022,12(1):6867.DOI:10.1038/s41598-022-10880-y.
[18] 向琴,叶鹏程,何蓉会,等.CD4细胞计数,IL-6/IL-10比值联合对艾滋病合并肺孢子菌肺炎的诊断价值[J].公共卫生与预防医学,2020,31(1):95-99.DOI:10.3969/j.issn.1006-2483.2020.01.022.
[19] 王爱媛,张婷,李春双,等.糖尿病肾病患者血CD64、Alb、IL-6表达及其与合并肺部感染的关系和预后影响因素[J].中国老年学杂志,2022,42(3):547-550.DOI:10.3969/j.issn.1005-9202.2022.03.011.
[20] Parthasarathi A,Padashetti VC,Padukudru S,et al.Association of Serum Albumin and Copeptin with Early Clinical Deterioration and Instability in Community-Acquired Pneumonia[J].Adv Respir Med,2022,90(4):323-337.DOI:10.3390/arm90040042.
[21] 黄亚萍,徐向君,蒋静,等.血清指标与老年尿毒症感染患者IPS评分的关系及临床意义[J].热带医学杂志,2022,22(11):1547-1550.DOI:10.3969/j.issn.1672-3619.2022.11.019.
[22] 张晓荣,李微.HBP、sCD14-ST与IPS评分对PCNL术后发生尿源性脓毒血症的预测价值[J].医学临床研究,2022,39(9):1345-1348.DOI:10.3969/j.issn.1671-7171.2022.09.018.
[23] Moriyama K,Ando T,Kotani M,et al.Risk factors associated with increased incidences of catheter-related bloodstream infection[J].Medicine (Baltimore),2022,101(42):e31160.DOI:10.1097/MD.0000000000031160.
[24] Bardi T,Pintado V,Gomez-Rojo M,et al.Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome[J].Eur J Clin Microbiol Infect Dis,2021,40(3):495-502.DOI:10.1007/s10096-020-04142-w.
[25] 潘珏蓉,韦卉,陈滢,等.血清中糖化血红蛋白和白蛋白水平预测妊娠期糖尿病产妇剖宫产术后感染风险的临床价值[J].河北医学,2021,27(7):1205-1209.DOI:10.3969/j.issn.1006-6233.2021.07.032.